• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促进对药物治疗方案依从性数据的分析。

Facilitated analysis of data on drug regimen compliance.

作者信息

de Klerk E, van der Linden S, van der Heijde D, Urquhart J

机构信息

Department of Internal Medicine, University Hospital Maastricht, The Netherlands.

出版信息

Stat Med. 1997 Jul 30;16(14):1653-64. doi: 10.1002/(sici)1097-0258(19970730)16:14<1653::aid-sim591>3.0.co;2-#.

DOI:10.1002/(sici)1097-0258(19970730)16:14<1653::aid-sim591>3.0.co;2-#
PMID:9257419
Abstract

Drug actions depend on dose and intervals between doses, in ways that are drug-specific and sometimes complex, complicating the use of drug dosing histories as an explanatory variable in the analysis of clinical trials. We describe a spread-sheet method for conveniently displaying patients' drug dosing histories, to facilitate identification of dosing correlates of clinically important events.

摘要

药物作用取决于剂量和给药间隔,其方式具有药物特异性,有时还很复杂,这使得在临床试验分析中使用用药史作为解释变量变得复杂。我们描述了一种电子表格方法,用于方便地展示患者的用药史,以促进识别临床重要事件的给药相关性。

相似文献

1
Facilitated analysis of data on drug regimen compliance.促进对药物治疗方案依从性数据的分析。
Stat Med. 1997 Jul 30;16(14):1653-64. doi: 10.1002/(sici)1097-0258(19970730)16:14<1653::aid-sim591>3.0.co;2-#.
2
Compliance monitoring of NSAID drug therapy in ankylosing spondylitis, experiences with an electronic monitoring device.强直性脊柱炎中NSAID药物治疗的依从性监测:使用电子监测设备的经验
Br J Rheumatol. 1996 Jan;35(1):60-5. doi: 10.1093/rheumatology/35.1.60.
3
A 12-week double-blind study of the efficacy, safety and tolerance of pirazolac b.i.d. compared with indomethacin t.i.d. in patients with ankylosing spondylitis.一项为期12周的双盲研究,比较吡唑拉酸每日两次与消炎痛每日三次治疗强直性脊柱炎患者的疗效、安全性和耐受性。
Drugs Exp Clin Res. 1990;16(1):29-37.
4
Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly.接受每周一次50毫克和每周两次25毫克依那西普治疗的强直性脊柱炎患者的患者报告结局有所改善。
Rheumatology (Oxford). 2007 Jun;46(6):999-1004. doi: 10.1093/rheumatology/kem069. Epub 2007 Mar 27.
5
Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial.强直性脊柱炎:临床研究的最佳时长是多久?一项为期一年与一项为期六周的非甾体抗炎药试验对比。
Rheumatology (Oxford). 1999 Mar;38(3):235-44. doi: 10.1093/rheumatology/38.3.235.
6
Ximoprofen in ankylosing spondylitis. A double blind placebo controlled dose ranging study.
Scand J Rheumatol. 1994;23(5):243-8. doi: 10.3109/03009749409103723.
7
Carprofen in ankylosing spondylitis.卡洛芬用于强直性脊柱炎。
Eur J Rheumatol Inflamm. 1982;5(4):527-35.
8
Double-blind, parallel clinical trial of tenoxicam (Ro 12-0068) versus piroxicam in patients with ankylosing spondylitis.
Eur J Rheumatol Inflamm. 1987;9(2):70-3.
9
Nonsteroidal antiinflammatory drug intake according to the Assessment of SpondyloArthritis International Society Score in clinical trials evaluating tumor necrosis factor blockers: example of etanercept in advanced ankylosing spondylitis.非甾体抗炎药的摄入根据评估脊柱关节炎国际协会评分在临床试验评估肿瘤坏死因子阻滞剂:依那西普在晚期强直性脊柱炎的例子。
Arthritis Care Res (Hoboken). 2012 Feb;64(2):290-4. doi: 10.1002/acr.20671.
10
A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis: comment on the article by Maksymowych et al.静脉注射帕米膦酸盐(60毫克与10毫克)治疗非甾体抗炎药难治性强直性脊柱炎的六个月随机、对照、双盲、剂量反应比较:对Maksymowych等人文章的评论
Arthritis Rheum. 2003 Feb;48(2):583-4; author reply 584. doi: 10.1002/art.10717.

引用本文的文献

1
An internal pilot study for a randomized trial aimed at evaluating the effectiveness of iron interventions in children with non-anemic iron deficiency: the OptEC trial.一项旨在评估铁干预措施对非贫血性缺铁儿童有效性的随机试验的内部预试验:OptEC试验。
Trials. 2015 Jul 14;16:303. doi: 10.1186/s13063-015-0829-4.
2
Optimizing early child development for young children with non-anemic iron deficiency in the primary care practice setting (OptEC): study protocol for a randomized controlled trial.在初级保健实践环境中优化非贫血性缺铁幼儿的早期儿童发育(OptEC):一项随机对照试验的研究方案
Trials. 2015 Apr 2;16:132. doi: 10.1186/s13063-015-0635-z.
3
Estimation of population pharmacokinetic parameters in the presence of non-compliance.
存在不依从性情况下的群体药代动力学参数估计
J Pharmacokinet Pharmacodyn. 2003 Feb;30(1):53-81. doi: 10.1023/a:1023297426153.
4
Assessment of Markov-dependent stochastic models for drug administration compliance.
Clin Pharmacokinet. 2003;42(2):193-204. doi: 10.2165/00003088-200342020-00006.
5
The electronic medication event monitor. Lessons for pharmacotherapy.电子药物事件监测仪。药物治疗的经验教训。
Clin Pharmacokinet. 1997 May;32(5):345-56. doi: 10.2165/00003088-199732050-00001.